================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report: September 26, 2003 Date of earliest event reported: September 24, 2003 BRISTOL-MYERS SQUIBB COMPANY (Exact name of registrant as specified in its charter) Delaware 1-1136 22-079-0350 (State or other jurisdiction (Commission file (IRS Employer of incorporation) number) Identification Number) 345 Park Avenue New York, NY 10154 (Address of principal executive office) Registrant's telephone number, including area code: (212) 546-4000 ================================================================================ Item 7 (c). Exhibits Exhibit 99 - Press release of Bristol-Myers Squibb Company dated September 24, 2003 announcing the intention to offer convertible senior debentures. Item 9. Regulation FD Disclosure On September 24, 2003, Bristol-Myers Squibb Company issued a press release announcing the intention to offer $1 billion of convertible senior debentures. A copy of the press release is furnished as Exhibit 99 to this report and is incorporated herein by reference. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Bristol-Myers Squibb Company, By: /s/ Sandra Leung ------------------------------------- Name: Sandra Leung Title: Secretary Date: September 26, 2003 EXHIBIT INDEX EXHIBIT NO. DESCRIPTION ----------- ----------- 99 Press Release dated September 24, 2003 of Bristol-Myers Squibb Company